These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 18450601)
1. The FDA, preemption, and the Supreme Court. Glantz LH; Annas GJ N Engl J Med; 2008 May; 358(18):1883-5. PubMed ID: 18450601 [No Abstract] [Full Text] [Related]
2. Why doctors should worry about preemption. Curfman GD; Morrissey S; Drazen JM N Engl J Med; 2008 Jul; 359(1):1-3. PubMed ID: 18596269 [No Abstract] [Full Text] [Related]
3. Good law from tragic facts--Congress, the FDA, and preemption. Annas GJ N Engl J Med; 2009 Sep; 361(12):1206-11. PubMed ID: 19759383 [No Abstract] [Full Text] [Related]
4. A pivotal medical-device case. Greenspan H N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18420514 [No Abstract] [Full Text] [Related]
5. A pivotal medical-device case. Picca SM N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18426011 [No Abstract] [Full Text] [Related]
6. The need for federal preemption of state tort claims in the context of "new drugs" and premarket-approved medical devices. Mottes LM Seton Hall Law Rev; 2011; 41(2):723-63. PubMed ID: 21739761 [No Abstract] [Full Text] [Related]
7. A pivotal medical-device case. Curfman GD; Morrissey S; Drazen JM N Engl J Med; 2008 Jan; 358(1):76-7. PubMed ID: 18172178 [No Abstract] [Full Text] [Related]
8. Losing deference in the FDA's second century: judicial review, politics, and a diminished legacy of expertise. O'Reilly JT Cornell Law Rev; 2008 Jul; 93(5):939-80. PubMed ID: 18618965 [No Abstract] [Full Text] [Related]
9. The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'Reilly. Vladeck DC Cornell Law Rev; 2008 Jul; 93(5):981-1002. PubMed ID: 18618967 [No Abstract] [Full Text] [Related]
10. A pivotal medical-device case. Sonder G N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18426012 [No Abstract] [Full Text] [Related]
11. Express preemption and premarket approval under the Medical Device Amendments. Scandaglia GJ; Tully TL Food Drug Law J; 2004; 59(2):245-64. PubMed ID: 15318395 [No Abstract] [Full Text] [Related]
12. Should preemption apply in a pharmaceutical context? An analysis of the preemption debate and what regulatory compliance statutes contribute to the discussion. Surprenant JA Fordham Law Rev; 2008 Oct; 77(1):327-63. PubMed ID: 18982554 [TBL] [Abstract][Full Text] [Related]
13. The Supreme Court, preemption, and malpractice liability. Kesselheim AS; Studdert DM N Engl J Med; 2009 Feb; 360(6):559-61. PubMed ID: 19196672 [No Abstract] [Full Text] [Related]
14. Bad medicine: prescription drugs, preemption, and the potential for a no-fault fix. Smirniotopoulos A Rev Law Soc Change; 2012; 35(4):793-862. PubMed ID: 22363960 [TBL] [Abstract][Full Text] [Related]
15. Exemption from federal preemption of state and local cigarette and smokeless tobacco requirements; revocation. Food and Drug Administration, HHS. Final rule. Fed Regist; 2000 Nov; 65(216):66636. PubMed ID: 11503697 [TBL] [Abstract][Full Text] [Related]
16. Permitting product liability litigation for FDA-approved drugs and devices promotes patient safety. Kesselheim AS Clin Pharmacol Ther; 2010 Jun; 87(6):645-7. PubMed ID: 20485322 [TBL] [Abstract][Full Text] [Related]
17. Judicial review of FDA preemption determinations. Frost A Food Drug Law J; 1999; 54(3):367-88. PubMed ID: 11797704 [No Abstract] [Full Text] [Related]
19. The Medical Device Safety Act of 2009. Curfman GD; Morrissey S; Drazen JM N Engl J Med; 2009 Apr; 360(15):1550-1. PubMed ID: 19297562 [No Abstract] [Full Text] [Related]
20. Life after Riegel: a fresh look at medical device preemption one year after Riegel v. Medtronic, Inc. Wartman GJ Food Drug Law J; 2009; 64(2):291-311. PubMed ID: 19999286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]